GlaxoSmithKline Plc lured another executive from California’s biotech hotbed in a bid to step up its artificial intelligence efforts and revitalise drug research.
Kim Branson will oversee the use of AI to find novel targets for potential medicines, where Glaxo believes the technology can have the biggest impact, the London-based drugmaker said. Branson is the latest top manager Glaxo has recruited from Roche Holding AG’s Genentech unit, based in San Francisco.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!